Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360399 · ClinicalTrials.gov registry record · NA
Identifying Factors That Predict Antidepressant Treatment Response
A NA study of Depression, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 344
- Enrollment target
- 2
- Study locations
NCT00360399: Completed NA study of Depression, sponsored by Emory University.
NCT00360399 is a NA study of Depression that has completed, run by Emory University. The registered enrollment target is 344 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00360399, a NA study of Depression, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 344 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare different treatments for depression in order to identify which factors predict effectiveness, and will include a companion study which investigates combining treatments and long term effectiveness.
Primary Outcome
The percentage of participants who achieved remission from a major depressive episode, using a last observation carried forward (LOCF) dataset, defined as all randomized patients who initiated treatment and had at least one follow-up rating assessment. A score of equal to or greater than 7 on the Hamilton Depression Rating Scale (HDRS) at the last observation was considered to be remission from depression.
Conditions Studied
Interventions
- DRUG Duloxetine
- DRUG Escitalopram
- BEHAVIORAL Cognitive behavioral therapy (CBT)
Study Locations (2)
Georgia
- Emory University Mood and Anxiety Disorders Program - Atlanta
- Emory University School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2006-08 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT00360399 record still lists
NCT00360399 is an interventional study that assigns participants to a tested intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Duloxetine is the first listed.
NCT00360399 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00360399 about?
NCT00360399 is a clinical study titled "Identifying Factors That Predict Antidepressant Treatment Response". This study will compare different treatments for depression in order to identify which factors predict effectiveness, and will include a companion study which investigates combining treatments and long term effectiveness.
What is the current status of trial NCT00360399?
This trial is currently completed. It is a NA study. The enrollment target is 344 participants. The study started on 2006-08. Estimated completion is 2015-04.
What conditions does trial NCT00360399 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00360399?
The interventions under investigation include: Duloxetine (DRUG), Escitalopram (DRUG), Cognitive behavioral therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00360399?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00360399 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00360399's enrollment target sits among peer trials
344 125th of 679 higher than 555 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia